Comparison of PrASE and Pyrosequencing for SNP Genotyping by Käller, Max et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
BMC Genomics
Open Access Methodology article
Comparison of PrASE and Pyrosequencing for SNP Genotyping
Max Käller1,4, Emilie Hultin1, Kristina Holmberg1, Marie-Louise Persson2, 
Jacob Odeberg1,3, Joakim Lundeberg*1 and Afshin Ahmadian1
Address: 1Department of Biotechnology, Royal Institute of Technology (KTH), AlbaNova University Center, Roslagstullsbacken 21, SE – 106 91 
Stockholm, Sweden, 2Clinical Chemistry Laboratory, Blekinge Hospital, Karlskrona, Sweden, 3Department of Medicine, Atherosclerosis Research 
Unit, King Gustaf V Research Institute, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden and 4Stanford Genome 
Technology Center, Stanford University, Palo Alto, CA 94304, USA
Email: Max Käller - maxk@biotech.kth.se; Emilie Hultin - emilie@biotech.kth.se; Kristina Holmberg - kicki@biotech.kth.se; Marie-
Louise Persson - marie-louise.persson@ltblekinge.se; Jacob Odeberg - jacob@biotech.kth.se; 
Joakim Lundeberg* - joakim.lundeberg@biotech.kth.se; Afshin Ahmadian - afshin@biotech.kth.se
* Corresponding author    
Abstract
Background: There is an imperative need for SNP genotyping technologies that are cost-effective
per sample with retained high accuracy, throughput and flexibility. We have developed a
microarray-based technique and compared it to Pyrosequencing. In the protease-mediated allele-
specific extension (PrASE), the protease constrains the elongation reaction and thus prevents
incorrect nucleotide incorporation to mismatched 3'-termini primers.
Results:  The assay is automated for 48 genotyping reactions in parallel followed by a tag-
microarray detection system. A script automatically visualizes the results in cluster diagrams and
assigns the genotypes. Ten polymorphic positions suggested as prothrombotic genetic variations
were analyzed with Pyrosequencing and PrASE technologies in 442 samples and 99.8 %
concordance was achieved. In addition to accuracy, the robustness and reproducibility of the
technique has been investigated.
Conclusion: The results of this study strongly indicate that the PrASE technology can offer
significant improvements in terms of accuracy and robustness and thereof increased number of
typeable SNPs.
Background
It is now a common belief that single nucleotide varia-
tions in the human genome are responsible for influenc-
ing traits such as differences in drug metabolism and
disease risk. These variations are referred to as single
nucleotide polymorphisms (SNPs) and several large-scale
technologies have recently been developed for scoring of
thousands of SNPs and approaching whole-genome gen-
otyping [1-5].
However, for smaller scale projects where potential genes
are already known, technologies for genotyping of many
samples instead of SNPs and in addition retain high accu-
racy and throughput, are more attractive compared to
assays that are cost effective per SNP. A flexible choice of
SNPs is also important instead of a pre-defined set of
SNPs. There are several technologies already used in aca-
demic contexts but the earliest paralleled assays relied
upon hybridization of short allele-specific probes to the
target DNA [6,7]. However, improvements in microarray-
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based technologies in terms of accuracy have been
achieved by enzymatic means [8-10]. One of these tech-
nologies involves allele-specific extension (ASE) which
utilizes the ability of DNA polymerase to distinguish
matched and mismatched 3'-termini of primers. How-
ever, a number of reports have shown that some mis-
matched 3'-ends can be elongated, giving false positive
signals [11-13]. Nevertheless, as previously described, by
exploiting the fact that the mismatched primers have
slower reaction kinetics, the problems associated with ASE
can be circumvented by including a protease (Proteinase
K) that degrades the polymerase [14]. In the protease-
mediated allele-specific extension (PrASE), the protease
constrains the elongation reaction and thus prevents
incorrect nucleotide incorporation to mismatched 3'-ter-
mini primers.
In this work, an automated PrASE assay with a tag-micro-
array detection system has been used and a comprehen-
sive comparison of genotyping results with
Pyrosequencing [15,16] has been done. Ten polymorphic
positions previously studied with Pyrosequencing [17] for
their suggested association as prothrombotic genetic vari-
ations [18-20] were used (Table 1, amplicon GC contents
of 38 to 69%). These were analyzed on genomic DNA
from unrelated DNA samples of Caucasian/Scandinavian
origin from a cohort of patients presenting with symp-
toms of acute chest pain [17]. A total of 4420 genotypes
were scored by each method and accordingly this study
offers a thorough characterization of a microarray-based
technique in terms of accuracy, robustness and variability.
Results and discussion
The PrASE assay employed for parallel genotyping of
SNPs is outlined in Figure 1 with some minor modifica-
tions to the original protocol [14], see Methods for details.
Extracted genomic DNA is amplified in a nested PCR to
achieve high specificity as well as to avoid extensive opti-
mization of the multiplex amplification. Amplicons of
minimal and similar sizes (48–58 bp) were chosen for the
inner PCR to minimize the amount of PCR optimizations.
The amplification products are immobilized on magnetic
beads via biotin-streptavidin binding. By using a solid
phase reaction, full automation of 48 genotyping reac-
tions in parallel could be facilitated with a magnet-
equipped pipetting robot. The washes of the 12 robot tips
were now optimized to keep contaminations between
sample rows undetectable (see description of results
below). The genotyping protocol takes approximately 2.5
hands-off hours and 30 minutes of hands-on. This was
followed by a one hour microarray detection of the 48
samples on one standard slide. In brief, after PCR product
immobilization and clean-ups, the allele-specific exten-
sion primers are hybridized to ssDNA and the multiplex
PrASE reaction is carried out by use of Cy5 labeled dNTPs,
allowing fluorescence detection. The products of the
PrASE reaction are then hybridized to a tag-microarray via
unique tag-sequences included in the extension primers.
The generic signature tag-arrays allow the genotyping
results for the SNPs to be separated into different spots. A
custom made silicone rubber mask was used to divide
each slide into 48 identical wells (an array of microar-
rays), facilitating analysis of 48 samples in parallel. The
fluorescence signals for each pair of allele-specific primers
were counted with an image analysis software. A script
automatically visualizes the results as cluster diagrams for
each SNP and genotypes the samples by calculating allelic
fractions (AFs). AFs are set to be the intensity from allele
1 (i.e. spot 1) divided by the sum of intensities from both
alleles. The AFs are then plotted for each SNP against the
logarithm of the sum of both signals. An example of a raw
data image of an entire slide and the corresponding cluster
Table 1: Genotyped polymorphisms
Gene (alternative name) Abbreviation DbSNP number Polymorphism 
position (nt)
PrASE amplicon 
lenght
PrASE amplicon 
GC content
serpin peptidase inhibitor, clade E 
(plasminogen activator inhibitor 
type 1), member 1
SERPINE1 rs1799768 -675 (4G/5G) 48/49 0.61
nitric oxide synthase 3 NOS3 rs1799983 894 (G/T) 48 0.64
5,10-methylenetetrahydrofolate 
reductase
MTHFR rs1801133 667 (C/T) 53 0.48
integrin, beta 3 (platelet 
glycoprotein IIIa)
ITGB3 rs5918 196 (T/C) 49 0.62
fibrinogen beta chain FGB rs1800791 -854 (G/A) 56 0.38
coagulation factor XIII, A1 
polypeptide
F13A1 rs5985 163 (G/T) 46 0.69
coagulation factor VII F7 rs510317 -402 (G/A) 56 0.40
coagulation factor V F5 rs6025 1691 (G/A) 54 0.45
coagulation factor II (thrombin) F2 rs1799963 20210 (G/A) 53 0.48
matrix metallopeptidase 3 
(stromelysin 1)
MMP3 rs3025058 -1675 (5T/6T) 57/58 0.42BMC Genomics 2006, 7:291 http://www.biomedcentral.com/1471-2164/7/291
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diagrams for the 48 samples on the slide is shown in Fig-
ure 2. The boundaries for the individual clusters are set as
± 3 SD from the mean AF within each cluster. This control
was used to increase stringency and thus data points that
fall outside clusters are classified as "no call".
To investigate the variability between tag sequences, each
allele-specific extension primer was designed with two
alternative tag sequences. The cluster diagrams for each of
the primer pair combinations were compared (data not
shown) and all combinations gave similar clusters as
compared to the diagrams presented in Figure 2, indicat-
ing that the cluster distributions were mainly related to
the extension rather than the hybridization properties of
the tag sequence. However, for ITGB3 the clusters were
shifted towards the left but functional when using one of
the primer pairs. This can be due to either differences in
hybridization efficiency or failure in the primer synthesis.
In addition, in order to investigate the effect of protease
on genotyping calls, eight samples were genotyped in the
presence and absence of protease. Without protease
(ASE), correct clustering could be obtained for 8 out of the
10 SNPs whereas with protease (PrASE) correct clustering
was obtained for all SNPs. The SNPs that did not render 3
distinguishable clusters by ASE are located in the ITGB3
and FGB genes (Figure S1 from Additional File 1). In these
cases, the mismatch primer was mistakenly extended for
one of the homozygous types, making these samples
appear as heterozygotes. The Pyrosequencing assay was
employed on these SNPs, confirming the PrASE results. In
addition, in the remaining 8 SNPs, the inclusion of pro-
tease renders complete partitioning of the clusters by
increasing the distance between clusters, indicating the
higher robustness of PrASE. These findings are consistent
with previous reports indicating lack of specificity of the
ASE assay [9,13,21,22].
Genotyping of 442 samples (4420 genotypes) was per-
formed side-by-side with PrASE and Pyrosequencing to
investigate the accuracy of the methods. All loci were
amplified in an outer 10-plex PCR followed by an inner
10-plex PCR for genotyping with PrASE and also 10 inner
simplex PCR reactions for genotyping with Pyrosequenc-
ing. Pyrosequencing was performed as previously
described [17]. A 99.8 % concordance was achieved
between the two assays. Eight discordant genotypes were
observed and these results were evenly distributed among
all SNPs and PCR-plates (Table 2). Five of the ambiguities
were settled with Sanger DNA sequencing as a third inde-
pendent method, unfortunately there were no remaining
genomic DNA of the last three samples. PrASE was correct
in four of the cases and Pyrosequencing in one case.
The robustness of the PrASE technology could be demon-
strated by examining the genotyping data for all 442 sam-
ples in the same cluster diagrams (See Figure 3). Each SNP
gave a distinct individual pattern that is very reproducible
between runs (48 samples at each run). No traces of sig-
nificant contamination is visible, in such a case the clus-
ters would be indistinguishable. In fact, as seen in early
results, before good conditions for the silicone rubber
mask that divides the slide into 48 wells was found, a con-
tamination in a sample is obvious in its placement
between clusters for several SNPs. This is a clear advantage
of a multiplex detection system as opposed to the single-
plex of Pyrosequencing where a contamination is not
always as obvious. Furthermore, as indicators of contam-
inations five negative and one positive controls were
included in each 96-well PCR plate. The negative controls
typically gave lower signal intensities than positives and
positioned themselves between clusters.
In fact, all 10 SNPs can be combined into a single plot of
4420 genotypes (Figure 3 right panel) and still form three
distinct clusters. Nevertheless, the obvious differences in
cluster patterns between different SNPs can be explained
by variations in sequence context (Figure 4), affecting
hybridization of extension primers to the target molecules
and to the spotted signature tags. The variation in MMP3
is a 5T/6T insertion/deletion that may be difficult to ana-
lyze due to 3'-terminus instability of hybridized probes to
this locus. In fact, MMP3 works very well considering that
one of the allele-specific primers ends with six deoxythy-
midines and the other one ends with five deoxythymi-
dines and a deoxycytidine theoretically giving the primers
very different duplex stabilities at the 3'-terminus.
In addition to accuracy and robustness, the reproducibil-
ity of the method was investigated by analyzing 24 sam-
ples. The investigated samples were all derived from the
same PCR reactions and divided into two PrASE reactions
followed by hybridization to one microarray slide. Stand-
ard deviations (SDs) were calculated between the two
allelic fractions for each sample. The mean SD was 0.018
for all SNPs while for the individual SNPs, the mean SD
ranged between 0.0047 and 0.030. Furthermore, 12 sam-
ples were assayed twice on separate dates (four months
apart and with different inner PCR reactions, batches of
microarray slides, enzymes and reagents). A mean SD of
0.023 was obtained for the two separate runs and for the
individual SNPs the SD ranged between 0.0054 and
0.039. The results here show that there is very little inter
and intra chip variability proving the reproducibility of
the assay. In addition, low SDs reflects tightly held clusters
(see Figure 1).BMC Genomics 2006, 7:291 http://www.biomedcentral.com/1471-2164/7/291
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SNP typing by PrASE Figure 1
SNP typing by PrASE. A nested multiplex PCR is performed to amplify all SNP loci in a single reaction. The biotin-labeled 
inner PCR products are captured by streptavidin-coated magnetic beads facilitating automated reaction clean-ups between all 
assay steps. Strand-specific alkali elution is then performed before hybridization of allele-specific extension primers which con-
tain unique tag sequences for later microarray detection. The multiplex PrASE reaction is performed with Cy5-labeled dNTPs 
to facilitate fluorescence detection. The products of the reaction are released with alkali, neutralized, and hybridized to a uni-
versal tag microarray containing 48 identical wells before detection.
Outer multiplex PCR products
Inner multiplex PCR
Immobilization and primer hybridization 
PrASE reaction with labeled dNTPs
Hybridization to 
48 well tag-array BMC Genomics 2006, 7:291 http://www.biomedcentral.com/1471-2164/7/291
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An array-of-microarrays and the corresponding clusters Figure 2
An array-of-microarrays and the corresponding clusters. 48 subarrays are spotted to each glass each having the entire 
set of 40 anti-tags spotted in triplicates (left panel insert) thus constituting an array-of-arrays (left panel). The colors are artifi-
cially added according to signal intensity by the software. The two signals for each SNP are plotted together as cluster diagrams 
where the three clusters represent each of the three possible genotypes (right panel). Allelic fractions (AFs, x-axes) are calcu-
lated from the signal intensities as spot 1/(spot 1 + spot 2) and logarithm of the total signal is used for the y-axes. To investigate 
the variability between tag sequences, each allele-specific extension primer was designed with two alternative tag sequences. 
All combinations for each SNP gave similar clusters to the presented.
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Conclusion
As a complement to whole-genome SNP typing technolo-
gies, where a large number of SNPs are examined in each
sample, there is an important niche for technologies that
accurately can type a large number of samples in not as
many SNPs. In this work, genotyping of ten polymor-
phisms associated with thrombosis formation was per-
formed with PrASE and 99.8% concordance was met
when data was compared to Pyrosequencing. However,
the PrASE assay proved to be considerably less labor
intensive due to its multiplexing capability in both PCR
amplification and genotyping. Yet, the number of investi-
gated SNPs per sample may be further increased by design
and addition of more signature tags on the arrays.
There is a plentitude of genotyping technologies with sim-
ilar multiplexing and sample capabilities as PrASE. Some
have been commercialized and are available in with spe-
cialized instruments and kits which naturally reduce the
complexity for the user but at the same time increases
costs and reduces the degrees of freedom for the
researcher. Some such as PrASE have only been described
academically and it is therefore difficult to get a simple
price quote but in this particular case running costs is in
the range of 0.15 USD per SNP.
Some other techniques in the same applicaton niche as
PrASE are limited in multiplexing capacity by the tech-
nique itself, such as Pyrosequencing and various real time
PCR assays (5' nuclease assay or TaqMan [23] and molec-
ular beacons [24]), whereas others are limited by the
amplification method, such as single-base extension
(SBE) [10] with microarray [25] or MALDI-TOF MS [26]
detection and PrASE. With MS detection, SBE has been
limited to 30-plex detection due to a limited number of
mass tags available or the resolution of the system [27].
The similar microarray platforms used for SBE and PrASE
would most likely be of similar multiplexing levels except
that PrASE uses the double amount of primers (a negligi-
ble cost in the case for many samples and moderate
number of SNPs) and thus uses double the amount of
spots on the microarray whereas SBE instead uses a two or
four color detection hence a more expensive scanner. The
multiplexing level for PrASE or conventional allele-spe-
cific extension (ASE) and SBE seems to be much larger
than previously anticipated; the same researchers have
compared 650 SNPs with ASE and SBE [28] and both
methods are scalable to hundreds of thousands of SNPs in
a single reaction [29]. The premises upon which these
were chosen are not clear and it is our belief that PrASE
technology can offer significant improvements in terms of
accuracy and robustness and thereof increase the number
of typeable SNPs, i.e. a more flexible choice in SNPs. This
is especially important since the most common biallelic
variations in the human genome is the C-T and the G-A
transitions that are also the most difficult polymorphisms
to type by allele specific extensions if not the PrASE tech-
nology is employed.
Methods
SNPs
Ten SNPs and single base insertions/deletions in as many
genes were selected that have been suggested as prothrom-
botic genetic variations. Gene names, abbreviations and
GenBank accession numbers as well as polymorphism
positions and types can be found in Table 1. Note that the
polymorphisms in SERPINE1 and MMP3 are single base
insertions/deletions. The SERPINE1 variation is a 4 or 5
deoxyguanosine residues while the MMP3 variation is a 5
or 6 deoxythymidine residues.
Patients
DNA was extracted from blood from unrelated individu-
als of Caucasian/Scandinavian origin (from a cohort of
patients presenting with symptoms of acute chest pain)
[17]. The patients were included in the Carlscrona Heart
Attack Prognosis Study approved by the ethics committee
at the University of Lund, Sweden in compliance with the
Declaration of Helsinki. Each 96-well PCR plate also con-
tained five negative water controls and one positive con-
trol (Clontech Laboratories, Palo Alto, CA, USA). To
prevent contamination problems three semi-clean rooms
with limitations to the DNA allowed in the rooms were
used.
Table 2: Conflicting results
SNP PCR Plate Well PrASE Pyrosequencing Sanger DNA sequencing
NOS3 A15 A5 AC AA nr
NOS3 A15 A8 CC AC nr
F7 A19 F9 AG AA AG
FGB A19 H9 GG AG AG
F7 A21 G10 AG AA AG
SERPINE1 A21 H7 AA CA nr
FGB A24 B6 GG AG GG
FGB A24 C6 GG AG GG
Note: nr = not resolvedBMC Genomics 2006, 7:291 http://www.biomedcentral.com/1471-2164/7/291
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Robustness of the assay Figure 3
Robustness of the assay. All the 442 typed samples from all experiments plotted together for each of the SNPs. As illus-
trated, clusters of each SNP give the same pattern between runs indicating the robustness and consistency of the assay. In fact, 
the entire dataset can be clustered in one diagram (right panel), still forming three distinct and correct clusters.
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Outer PCR
A nested multiplex amplification of the genomic regions
was performed. The same outer PCR was used as template
both for 10 separate inner PCRs for Pyrosequencing as
well as an inner multiplex PCR, used for PrASE. All prim-
ers for PCR were designed from GenBank entries and
searched for specificity and were synthesized by MWG-
Biotech (Ebersberg, Germany) (Table S1 from Additional
File 1). The outer PCR was optimized by running gradient
PCRs and simplex inner PCRs. An equivalent of 1–5 ng
genomic DNA was used for each 25 μl reaction with 0.1
μM of each primer (except for the MTHFR-, F5- and F2-
regions which needed 0.14 μM). The PCR contained 2
mM MgCl2, 0.2 mM dNTP (Amersham Biosciences, Upp-
sala, Sweden) and 0.5 U AmpliTaq Gold with 1× PCR
Gold buffer (Applied Biosystems, Foster City, CA). The
amplification program was 94°C for 12 min followed by
35 cycles at 94°C 50 s, 65°C 30 s and 72°C 2 min and
finally 72°C for 10 min and it was performed on a Gene-
AMP thermocycler (PE Biosystems, Foster City, CA).
Inner Simplex PCRs for Pyrosequencing
0.5 μl of the outer PCR was used as template to separately
amplify each SNP region in inner PCRs with the same con-
centrations as above but using 0.2 U polymerase. One
primer in each pair was biotinylated for later immobiliza-
tion. Amplification program were as above with the
exceptions of 30 s of denaturation in each cycle and
annealing temperatures of 64.5°C for all SNPs but FGB
which annealed at 60°C and it was performed on a MWG
multi block thermocyclers (MWG-Biotech).
Inner Multiplex PCR for PrASE
0.5 μl of the outer PCR was used as template to amplify all
10 loci in 50 μl inner PCR reaction with the same concen-
trations as above except 0.04 μM of each of the 20 primers
Sequences of all PCR amplicons used for PrASE Figure 4
Sequences of all PCR amplicons used for PrASE. Inner multiplex PCR primers are underlined. The placement of PrASE 
and Pyrosequencing primers are indicated in bold and italic respectively. Note that the forward strand sequences are displayed 
hence the actual sequences of primers are reverse and complementary where appropriate.
SERPINE1
GGCACAGAGAGAGTCTGGACACGT(G/-)GGGGAGTCAGCCGTGTATCATCGG
NOS3
CTGCTGCTGCAGGCCCCAGATGA(G/T)CCCCCAGAACTCTTCCTTCTGCCC
MTHFR
TGAAGGAGAAGGTGTCTGCGGGAG(C/T)CGATTTCATCATCACGCAGCTTTTCTTT
ITGB3
CTCCTGTCTTACAGGCCCTGCCTC(C/T)GGGCTCACCTCGCTGTGACCTGAA
FGB
CAAGAGAGATAAATTTTGTGGCTTGTGG(G/A)AAATGAAGGAAAATGGGCCTCATTTAG
F13A1
CTGCCCACAGTGGAGCTTCAGGGC(G/T)TGGTGCCCCGGGGCGTCAACCT
F7
CAAATATTTACATCCACACCCAAGATAC(G/A)GTCTTGAGATTTGACTCGCATGATTGC
F5
TGTAAGAGCAGATCCCTGGACAGGC(G/A)AGGAATACAGGTATTTTGTCCTTGAAGT
F2
TGGTTCCCAATAAAAGTGACTCTCAGC(G/A)AGCCTCAATGCTCCCAGTGCTATTC
MMP3
GTATTTCAATCAGGACAAGACATGGTTTTT(T/-)CCCCCCATCAAAGGAATGGAGAACCATBMC Genomics 2006, 7:291 http://www.biomedcentral.com/1471-2164/7/291
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and using 1 U of Platinum Taq DNA polymerase with 1×
PCR buffer (Invitrogen AB, Lidingö, Sweden). Primers are
indicated in Table S1 from Additional File 1 and one
primer in each pair was biotinylated for immobilization.
The amplification program was 94°C for 5 min followed
by 45 cycles at 94°C 30 s, 60°C 30 s and 72°C 30 s and
finally 72°C for 10 min and it was performed on a Gene-
AMP thermocycler (PE Biosystems).
Pyrosequencing
Single stranded DNA was generated by the use of immo-
bilization of the biotinylated PCR products to 50 μg of
streptavidin coated super paramagnetic beads (Dyna-
beads M-270, Dynal Biotech, Oslo, Norway) and 1.65
pmol Pyrosequencing primer (Table S1 from Additional
File 1) was hybridized by the use of a Magnatrix 1200
pipetting robot (Magnetic Biosolutions, Stockholm, Swe-
den) according to the manufacturers' instructions. Pyrose-
quencing was performed according to manufacturer's
instructions on a PSQ™ 96 HS instrument (Biotage, Upp-
sala, Sweden) and analyzed with the accompanying SNP
software.
PrASE Reaction
The PrASE assay was automated by the use of a Magnatrix
1200 pipetting robot (Magnetic Biosolutions) that han-
dles magnetic beads used for streptavidin immobilization
of the biotinylated PCR products. The robot is capable of
handling 48 samples in parallel, which is the same
number as can be hybridized to one microarray slide. 200
μg streptavidin-coated super paramagnetic beads (Dyna-
beads M-280, Dynal Biotech) were used for each inner
multiplex PCR product. Immobilization and washes
between steps were made according to the manufacturer's
instructions and as described before [14]. Single-stranded
DNA was prepared by alkali treatment and annealed to
allele-specific extension primers (0.08 μM in 60 μl) (Table
S2 from Additional File 1). The PrASE reaction was per-
formed at 37°C in a total volume of 60 μl. containing 1×
extension buffer (42.5 mM Tris-HCl pH 8, 5 mM MgCl2
and 1 mM DTT), 0.25 % bovine serum albumin and 10 U
DNA polymerase (3'-5' exonuclease deficient Klenow
fragment, Fermentas, Helsingborg, Sweden). The PrASE
reaction was started by simultaneous addition of 1.5 μM
of each dNTP (Amersham Biosciences) and 20 μg Protei-
nase K (Invitrogen). 50 % of the dCTP and dUTP were Cy5
labeled to allow fluorescence detection of extended prim-
ers. Strand-specific alkali elution of the primers was made
before hybridization to the tag-microarray.
Tag Microarrays
Tag microarrays were prepared as previously reported
[30]. Forty-eight oligonucleotides (MWG-Biotech) were
spotted (Q-array, Genetix, Hampshire, United Kingdom)
in triplicates onto glass slides (Code Link, Amersham
Biosceinces, Uppsala, Sweden). The oligonucleotide pat-
tern was repeated on each slide and these sub-arrays were
separated during hybridization using a silicone mask to
facilitate parallel analysis of 48 samples [31]. Hybridiza-
tion of the extended allele-specific primers was performed
at 50°C for 1 h. Each primer contained a specific tag at its
5'-end complementary to one of the 48 spotted oligonu-
cleotides. The slides were washed according to the manu-
facturer before scanning (Agilent scanner, Agilent
Technologies, Palo Alto, CA, USA). Data was extracted
with GenePix 5.0 software (Axon instruments, USA) and
analyzed with a custom Microsoft Excel script.
Sanger DNA sequencing
Conflicting results were resolved using Sanger dideoxy
sequencing with BigDye terminator chemistry (Applied
Biosystems, Foster City, CA) and an ABI 3700 Analyzer
instrument (Applied Biosystems). The same PCR setups as
for Pyrosequencing were used and the inner PCR primers
were used as sequencing primers.
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